DrugRisk Announces Launch of Da Vinci Surgery Resource Center
New York, NY (PRWEB) August 01, 2013 -- The prescription drug and medical device safety advocates at DrugRisk.com are announcing the launch of a new resource center for patients who have undergone surgery with the Intuitive da Vinci surgical robot amid recent safety warnings*.
DrugRisk provides patients using popular medical devices with the latest warnings, recalls, studies and legal news to improve safety and awareness. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.
The da Vinci robot was used in nearly 370,000 soft tissue procedures such as hysterectomies, gallbladder and thyroid removal and cancer surgeries last year*. The National Cancer Institute estimates the device is used in 80% of all prostatectomies**.
However, DrugRisk has added information from the FDA linking da Vinci to 212 injuries and 90 deaths, with reports of electrical burns, damage to ureters and bowels and invasive broken surgical tools***. The American College of Obstetricians and Gynecologists**** has also warned of increased reports of complications involving robotic surgery.
Now, the resource center has learned that the FDA has issued a warning letter to Intuitive Surgical, the maker of da Vinci, after the company didn’t report adverse events or risks to patients and the number of injury reports doubled in the first half of 2013*.
Lawyers are helping those who suffered injury after undergoing a robotic surgery learn their legal options. Anyone affected is encouraged to visit DrugRisk.com or speak with a lawyer about their legal options. Due to the specialized nature of these cases, DrugRisk only recommends lawyers who have already handled da Vinci lawsuits.
Visit http://www.DrugRisk.com today for more information on the warnings, side effects and litigation news related to da Vinci and other medical devices, or to speak with a lawyer.
*Bloomberg, 7/18/13; bloomberg.com/news/2013-07-18/intuitive-surgical-declines-on-warning-letter-from-fda.html
**NCI, 8/9/11; cancer.gov/ncicancerbulletin/080911/page4
***FDA MAUDE, 7/31/13; accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/results.cfm
****Fierce Medical Devices, 3/15/13; fiercemedicaldevices.com/story/intuitive-slides-doc-group-slams-robotic-surgery-hype/2013-03-15
Patient Advocate, DrugRisk, http://www.DrugRisk.com, 888-415-1859, [email protected]
Share this article